RU99106781A - 3-REPLACED PYRIDO DERIVATIVES [4 ', 3': 4,5] THIENO [2,3-ALPHA] PYRIMIDINE, THEIR RECEIVING AND APPLICATION - Google Patents
3-REPLACED PYRIDO DERIVATIVES [4 ', 3': 4,5] THIENO [2,3-ALPHA] PYRIMIDINE, THEIR RECEIVING AND APPLICATIONInfo
- Publication number
- RU99106781A RU99106781A RU99106781/04A RU99106781A RU99106781A RU 99106781 A RU99106781 A RU 99106781A RU 99106781/04 A RU99106781/04 A RU 99106781/04A RU 99106781 A RU99106781 A RU 99106781A RU 99106781 A RU99106781 A RU 99106781A
- Authority
- RU
- Russia
- Prior art keywords
- group
- carbon atoms
- residue
- alkyl
- atom
- Prior art date
Links
- CZPWVGJYEJSRLH-UHFFFAOYSA-N 289-95-2 Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 title 1
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical class CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 title 1
- 125000004432 carbon atoms Chemical group C* 0.000 claims 13
- 125000000217 alkyl group Chemical group 0.000 claims 7
- -1 if necessary group Chemical group 0.000 claims 7
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 claims 6
- 229910052757 nitrogen Inorganic materials 0.000 claims 5
- 125000004433 nitrogen atoms Chemical group N* 0.000 claims 5
- 125000005843 halogen group Chemical group 0.000 claims 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 4
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 4
- 125000003545 alkoxy group Chemical group 0.000 claims 3
- 125000003277 amino group Chemical group 0.000 claims 3
- 229910052799 carbon Inorganic materials 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 3
- 229910052736 halogen Inorganic materials 0.000 claims 3
- 125000004435 hydrogen atoms Chemical class [H]* 0.000 claims 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 3
- 125000004430 oxygen atoms Chemical group O* 0.000 claims 3
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 claims 2
- 229940076279 Serotonin Drugs 0.000 claims 2
- 230000003042 antagnostic Effects 0.000 claims 2
- 125000003118 aryl group Chemical group 0.000 claims 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 125000001841 imino group Chemical group [H]N=* 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 125000003884 phenylalkyl group Chemical group 0.000 claims 2
- HJRHKBYFZYLBCI-UHFFFAOYSA-N 1,4,5,6,7,8-hexahydropyrido[2,3]thieno[2,4-b]pyrimidine Chemical class N1C=NCC2=C1SC1=C2CCNC1 HJRHKBYFZYLBCI-UHFFFAOYSA-N 0.000 claims 1
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 claims 1
- 206010012378 Depression Diseases 0.000 claims 1
- 150000001335 aliphatic alkanes Chemical group 0.000 claims 1
- 239000005557 antagonist Substances 0.000 claims 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drugs Drugs 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 125000001326 naphthylalkyl group Chemical group 0.000 claims 1
- 125000002071 phenylalkoxy group Chemical group 0.000 claims 1
- 125000003373 pyrazinyl group Chemical group 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 claims 1
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 125000001424 substituent group Chemical group 0.000 claims 1
- 0 CC(C1*CCN2CC(*)CC2)=Cc([s]c(C*2)c3CN2I*)c3C1=* Chemical compound CC(C1*CCN2CC(*)CC2)=Cc([s]c(C*2)c3CN2I*)c3C1=* 0.000 description 1
Claims (6)
где R1 означает водород, алкил с 1 - 4 атомами углерода, ацетильную или бензоильную группу, фенилалкильный остаток с 1 - 4 атомами углерода в алкильном остатке, причем ароматический фрагмент при необходимости замещается галогеном, алкилом с 1 - 4 атомами углерода, трифторметилом, гидроксильной группой, алкоксигруппой с 1 - 4 атомами углерода, аминогруппой, циангруппой или нитрогруппой, нафтилалкильный остаток с 1 - 3 атомами углерода в алкиле, остаток фенилалканона с 2 - 3 атомами углерода в остатке алкана или фенилкарбамоилалкильный остаток с 2 атомами углерода в алкиле, причем фенильная группа может быть замещена галогеном,
R2 представляет собой при необходимости моно-, ди- или тризамещенную атомами галогена, алкилом с 1 - 4 атомами углерода, трифторметильными, трифторметоксильными, гидроксильными группами, алкоксигруппами с 1 - 4 атомами углерода, аминогруппами, монометиламиногруппами, диметиламино-, циан- или нитрогруппами фенильную, пиридильную, пиримидинильную или пиразинильную группу, которая при необходимости может быть анеллирована с шестичленным ароматическим ядром, которое при необходимости имеет один или два заместителя в виде атомов галогена, алкила с 1 - 4 атомами углерода, гидроксильной группы, трифторметильной группы, алкоксигруппы с 1 - 4 атомами углерода, аминогруппы, циангруппы или нитрогруппы и при необходимости может содержать один атом азота, или с 5- или 6-ти членным кольцом, которое может содержать 1 - 2 атома кислорода, или может быть замещена фенилалкильной группой или фенилалкоксигруппой с 1 - 2 атомами углерода в алкильном остатке, причем фенильный остаток может быть замещен галогеном, метильной группой, трифторметильной группой или метоксигруппой.1. 3-Substituted derivatives of 3,4,5,6,7,8-hexahydropyrido [4 ', 3': 4,5] thieno [2,3-d] pyrimidine of formula I
where R 1 means hydrogen, alkyl with 1-4 carbon atoms, acetyl or benzoyl group, phenylalkyl residue with 1-4 carbon atoms in the alkyl residue, and the aromatic fragment is replaced with halogen, alkyl with 1-4 carbon atoms, trifluoromethyl, hydroxyl, if necessary group, alkoxy group with 1-4 carbon atoms, amino group, cyano group or nitro group, naphthylalkyl residue with 1-3 carbon atoms in alkyl, the residue of phenylalkanone with 2-3 carbon atoms in the alkane residue or phenylcarbamoylalkyl residue with 2 atom amides of carbon in alkyl, wherein the phenyl group may be substituted with halogen,
R 2 represents, if necessary, mono-, di- or trisubstituted by halogen atoms, alkyl with 1-4 carbon atoms, trifluoromethyl, trifluoromethoxy, hydroxyl groups, alkoxy groups with 1-4 carbon atoms, amino groups, monomethylamino groups, dimethylamino, cyanorimer, or nitro groups phenyl, pyridyl, pyrimidinyl or pyrazinyl group, which if necessary can be anelated with a six-membered aromatic nucleus, which if necessary has one or two substituents in the form of halogen atoms, alky and with 1-4 carbon atoms, hydroxyl group, trifluoromethyl group, alkoxy group with 1-4 carbon atoms, amino group, cyano group or nitro group and, if necessary, may contain one nitrogen atom, or with 5- or 6-membered ring, which may contain 1 to 2 oxygen atoms, or it may be substituted by a phenylalkyl group or a phenylalkoxy group with 1 to 2 carbon atoms in the alkyl residue, and the phenyl residue may be replaced by a halogen, methyl group, trifluoromethyl group, or methoxy group.
В означает водород или метил,
С означает водород, метил или гидроксильную группу,
Х означает атом азота,
Y означает СН2, СН2-СН2, СН2-СН2-СН2 или СН2-СН,
Z означает атом азота, атом углерода или СН, причем связь между Y и Z может быть также двойной,
n означает число 2, 3 или 4,
а также их физиологически приемлемые соли.And means imino group or oxygen atom,
B is hydrogen or methyl,
C means hydrogen, methyl or hydroxyl group,
X means a nitrogen atom
Y means CH 2 , CH 2 -CH 2 , CH 2 -CH 2 -CH 2 or CH 2 -CH,
Z means a nitrogen atom, a carbon atom or a CH, and the bond between Y and Z can also be double,
n means the number 2, 3 or 4,
and their physiologically acceptable salts.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19636769A DE19636769A1 (en) | 1996-09-10 | 1996-09-10 | 3-Substituted pyrido [4 ', 3': 4,5] thieno [2,3-d] pyrimidine derivatives, their preparation and use |
DE19636769.7 | 1996-09-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU99106781A true RU99106781A (en) | 2001-04-27 |
RU2198888C2 RU2198888C2 (en) | 2003-02-20 |
Family
ID=7805168
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU99106781/04A RU2198888C2 (en) | 1996-09-10 | 1997-08-22 | 3-substituted derivatives of 3,4,5,6,7,8-hexahydro-pyrido-[4',3':4,5]-thieno[2,3- d]-pyrimidine |
Country Status (32)
Country | Link |
---|---|
US (1) | US6222034B1 (en) |
EP (1) | EP0927184B1 (en) |
JP (1) | JP2001500138A (en) |
KR (1) | KR20000035987A (en) |
CN (2) | CN1230962A (en) |
AR (1) | AR009572A1 (en) |
AT (1) | ATE252587T1 (en) |
AU (1) | AU736678B2 (en) |
BG (1) | BG63602B1 (en) |
BR (1) | BR9711724A (en) |
CA (1) | CA2265509A1 (en) |
CO (1) | CO4900071A1 (en) |
CZ (1) | CZ288896B6 (en) |
DE (2) | DE19636769A1 (en) |
DK (1) | DK0927184T3 (en) |
ES (1) | ES2210570T3 (en) |
HK (1) | HK1043593A1 (en) |
HR (1) | HRP970484A2 (en) |
HU (1) | HUP9904107A3 (en) |
ID (1) | ID18260A (en) |
IL (1) | IL128142A0 (en) |
NO (1) | NO991132D0 (en) |
NZ (1) | NZ334350A (en) |
PL (1) | PL332144A1 (en) |
PT (1) | PT927184E (en) |
RU (1) | RU2198888C2 (en) |
SK (1) | SK283039B6 (en) |
TR (1) | TR199900503T2 (en) |
TW (1) | TW480264B (en) |
UA (1) | UA54449C2 (en) |
WO (1) | WO1998011110A1 (en) |
ZA (1) | ZA978081B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2559626C2 (en) * | 2010-04-14 | 2015-08-10 | Байер Интеллектуэль Проперти Гмбх | Method of producing dithiine-tetracarboximides |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19724979A1 (en) * | 1997-06-13 | 1998-12-17 | Basf Ag | 3-Substituted pyrido [3,4,5] thieno [2,3-d] pyrimidine derivatives, their preparation and use |
DE19724980A1 (en) * | 1997-06-13 | 1998-12-17 | Basf Ag | 3-Substituted 3,4-dihydro-thieno [2,3-d] pyrimidine derivatives, their preparation and use |
DE19734444A1 (en) * | 1997-08-08 | 1999-02-11 | Basf Ag | 3-Substituted 3,4,5,7-tetrahydro-pyrrolo (3 ', 4': 4,5) thieno (2,3-d) pyrimidine derivatives, their preparation and use |
DE19900545A1 (en) | 1999-01-11 | 2000-07-13 | Basf Ag | Use of pyrimidine derivatives for the prophylaxis and therapy of cerebral ischemia |
DE19900673A1 (en) * | 1999-01-11 | 2000-07-13 | Basf Ag | Use of binding partners for 5-HT5 receptors for the treatment of neurodegenerative and neuropsychiatric disorders |
FR2791980B1 (en) * | 1999-04-09 | 2001-07-06 | Sod Conseils Rech Applic | PYRIDO-THIENO-DIAZEPINES, THEIR PREPARATION PROCESS, AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
DE10031390A1 (en) * | 2000-07-03 | 2002-01-17 | Knoll Ag | Pyrimidine derivatives and their use for the prophylaxis and therapy of cerebral ischemia |
DE10031389A1 (en) * | 2000-07-03 | 2002-01-17 | Knoll Ag | Pyrimidine derivatives and their use for the prophylaxis and therapy of cerebral ischemia |
JP5079202B2 (en) * | 2000-07-18 | 2012-11-21 | 大日本住友製薬株式会社 | Serotonin reuptake inhibitor |
DE10259382A1 (en) * | 2002-12-18 | 2004-07-01 | Abbott Gmbh & Co. Kg | 3-Substituted 3,4-dihydro-thieno [2,3-d] pyrimidin-4-one derivatives, their preparation and use |
US7612078B2 (en) * | 2003-03-31 | 2009-11-03 | Epix Delaware, Inc. | Piperidinylamino-thieno[2,3-D] pyrimidine compounds |
US7030240B2 (en) * | 2003-03-31 | 2006-04-18 | Predix Pharmaceuticals Holdings, Inc. | Piperidinylamino-thieno[2,3-d] pyrimidine compounds |
US20050222175A1 (en) * | 2004-03-31 | 2005-10-06 | Dhanoa Dale S | New piperidinylamino-thieno[2,3-D] pyrimidine compounds |
US20050165025A1 (en) * | 2004-01-22 | 2005-07-28 | Recordati Ireland Ltd. | Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists |
US7488736B2 (en) * | 2004-05-17 | 2009-02-10 | Epix Delaware, Inc. | Thienopyridinone compounds and methods of treatment |
US7598265B2 (en) * | 2004-09-30 | 2009-10-06 | Epix Delaware, Inc. | Compositions and methods for treating CNS disorders |
US7407966B2 (en) * | 2004-10-07 | 2008-08-05 | Epix Delaware, Inc. | Thienopyridinone compounds and methods of treatment |
US7576211B2 (en) * | 2004-09-30 | 2009-08-18 | Epix Delaware, Inc. | Synthesis of thienopyridinone compounds and related intermediates |
WO2010065743A2 (en) * | 2008-12-03 | 2010-06-10 | Nanotherapeutics, Inc. | Bicyclic compounds and methods of making and using same |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE272088C (en) * | ||||
DE272079C (en) * | ||||
DE272086C (en) * | ||||
DE1937459A1 (en) * | 1968-08-02 | 1970-02-05 | Ciba Geigy | Novel pyrimidine derivatives and processes for their preparation |
US3823151A (en) * | 1968-08-02 | 1974-07-09 | Ciba Geigy Corp | 4,5,6,7-tetrahydrothieno(2,3-d)pyridines |
JPS60146891A (en) * | 1984-01-05 | 1985-08-02 | Mitsubishi Chem Ind Ltd | (2,3-d)thienopyrimidine derivative and its salt |
EP0257102B1 (en) * | 1986-02-24 | 1997-11-19 | Mitsui Petrochemical Industries, Ltd. | Agents for treating neurophathy |
US5001130A (en) | 1988-02-18 | 1991-03-19 | Bristol-Myers Company | Psychotropic heterobicycloalkylpiperazine derivatives |
US4835157A (en) | 1988-03-15 | 1989-05-30 | Ortho Pharmaceutical Corporation | Thieno- and furopyrimidine-2,4-dione piperidine derivatives as serotonin antagonists and alpha adrenergic blocking agents |
-
1996
- 1996-09-10 DE DE19636769A patent/DE19636769A1/en not_active Withdrawn
-
1997
- 1997-08-22 CA CA002265509A patent/CA2265509A1/en not_active Abandoned
- 1997-08-22 NZ NZ334350A patent/NZ334350A/en unknown
- 1997-08-22 JP JP10513191A patent/JP2001500138A/en active Pending
- 1997-08-22 DK DK97940118T patent/DK0927184T3/en active
- 1997-08-22 CZ CZ1999759A patent/CZ288896B6/en not_active IP Right Cessation
- 1997-08-22 PL PL97332144A patent/PL332144A1/en unknown
- 1997-08-22 EP EP97940118A patent/EP0927184B1/en not_active Expired - Lifetime
- 1997-08-22 BR BR9711724A patent/BR9711724A/en not_active Application Discontinuation
- 1997-08-22 SK SK230-99A patent/SK283039B6/en unknown
- 1997-08-22 IL IL12814297A patent/IL128142A0/en unknown
- 1997-08-22 DE DE59710902T patent/DE59710902D1/en not_active Expired - Fee Related
- 1997-08-22 KR KR1019997001939A patent/KR20000035987A/en not_active Application Discontinuation
- 1997-08-22 US US09/254,449 patent/US6222034B1/en not_active Expired - Lifetime
- 1997-08-22 HU HU9904107A patent/HUP9904107A3/en unknown
- 1997-08-22 WO PCT/EP1997/004593 patent/WO1998011110A1/en not_active Application Discontinuation
- 1997-08-22 UA UA99042039A patent/UA54449C2/en unknown
- 1997-08-22 RU RU99106781/04A patent/RU2198888C2/en not_active IP Right Cessation
- 1997-08-22 TR TR1999/00503T patent/TR199900503T2/en unknown
- 1997-08-22 ES ES97940118T patent/ES2210570T3/en not_active Expired - Lifetime
- 1997-08-22 CN CN97197765A patent/CN1230962A/en active Pending
- 1997-08-22 PT PT97940118T patent/PT927184E/en unknown
- 1997-08-22 AT AT97940118T patent/ATE252587T1/en not_active IP Right Cessation
- 1997-08-22 AU AU42071/97A patent/AU736678B2/en not_active Ceased
- 1997-09-02 TW TW086112642A patent/TW480264B/en not_active IP Right Cessation
- 1997-09-09 CO CO97052337A patent/CO4900071A1/en unknown
- 1997-09-09 AR ARP970104118A patent/AR009572A1/en unknown
- 1997-09-09 ZA ZA978081A patent/ZA978081B/en unknown
- 1997-09-10 ID IDP973146A patent/ID18260A/en unknown
- 1997-09-10 HR HR19636769.7A patent/HRP970484A2/en not_active Application Discontinuation
-
1999
- 1999-01-27 BG BG103122A patent/BG63602B1/en unknown
- 1999-03-09 NO NO991132A patent/NO991132D0/en not_active Application Discontinuation
-
2001
- 2001-05-18 CN CN01116979A patent/CN1332168A/en active Pending
-
2002
- 2002-07-17 HK HK02105304.8A patent/HK1043593A1/en unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2559626C2 (en) * | 2010-04-14 | 2015-08-10 | Байер Интеллектуэль Проперти Гмбх | Method of producing dithiine-tetracarboximides |
RU2559626C9 (en) * | 2010-04-14 | 2016-05-27 | Байер Интеллектуэль Проперти Гмбх | Method of producing dithiine-tetracarboximides |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU99106781A (en) | 3-REPLACED PYRIDO DERIVATIVES [4 ', 3': 4,5] THIENO [2,3-ALPHA] PYRIMIDINE, THEIR RECEIVING AND APPLICATION | |
AR006906A1 (en) | SUBSTITUTED INDAZOL DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, USE OF THEM AND INTERMEDIARIES OF SYNTHESIS | |
NZ512731A (en) | Tricyclic inhibitors of poly(ADP-ribose) polymerases | |
WO2003106428A8 (en) | Arylsulphonamide derivatives and use thereof as b1 bradykinin receptor antagonists | |
CY1105688T1 (en) | Cyanopyrroles as Progesterone Receptor Agonists | |
JP2008517983A5 (en) | ||
KR950031113A (en) | Pyrrolopyrimidine Derivatives with Pharmacological Activity | |
NO983970L (en) | Tricyclic compounds, their preparation and use | |
BR9810017A (en) | Derived from 3 - substituted 3,4-dihydrothieno [2, 3d] pyrimidine, and, use of the same | |
NO991132L (en) | 3-Substituted pyrido [4 ', 3',: 4,5] thieno [2,3-D] pyrimidine derivatives, preparation and use thereof | |
ES8802518A1 (en) | Heterocyclic substituted-phenoxyalkyl-isoxazoles and-furans, their preparation and use as antiviral agents. | |
ES534505A0 (en) | A PROCEDURE FOR THE PREPARATION OF 1, 4-DIHYDROPYRIDINE COMPOUNDS | |
RU97115107A (en) | BICYCLIC DERIVATIVES OF ISOTHYOTURES USED IN THERAPY | |
ATE33831T1 (en) | ANALGESIC 5-HYDROXYTRYPTOPHAN DERIVATIVES. | |
DE60001622D1 (en) | Dihydrofuro- (3,4-b) -quinolein-1-one derivatives, processes for their preparation and pharmaceutical compositions containing them | |
MXPA04003278A (en) | 5-methoxy-8-aryl-[1,2,4] triazolo [1,5-a] pyridine derivatives as adenosine receptor antagonists. | |
NZ519126A (en) | Novel IL-8 receptor antagonists | |
DK0526588T3 (en) | Heterocyclic compounds, their preparation and use | |
RU2000100997A (en) | DERIVATIVES OF 3-SUBSTITUTED PYRIDO (3 ', 4': 4.5) THIENO (2,3-D) PYRIMIDINE | |
RU2000100996A (en) | 3-SUBSTITUTED DERIVATIVES 3,4-DIHYDRO-THYENO [2,3-D] PYRIMIDINE THEIR RECEPTION AND APPLICATION | |
EA200400770A1 (en) | DERIVATIVES 5- (PIRIDIN-3-IL) -1-AZABICYCLO [3.2.1] OKTANA, THEIR RECEIVING AND APPLICATION IN THERAPY | |
CO5090902A1 (en) | PIRROLES REPLACED | |
IS2419B (en) | Glycine-substituted thieno [2,3-d] pyrimidine with combined LH and FSH agonist activity | |
RU2000106033A (en) | 3-SUBSTITUTED 3,4,5,7-TETRAHYDROPYRROLO [3 ', 4': 4,5] THIENO [2,3-D] -PYRIMIDINE DERIVATIVES | |
RU2003130376A (en) | APPLICATION OF PYROINDOLONE DERIVATIVES FOR PREPARATION OF ANTI-CANCER MEDICINES |